UCB 583 Pill — PURPLE;WHITE CAPSULE, 22mm — Methylphenidate

No photo available

Imprint	UCB / 583
Colour	PURPLE;WHITE
Shape	CAPSULE
Size	22
Strength	methylphenidate hydrochloride 50 mg
Dosage form	Capsule, Extended Release
Manufacturer	Kremers Urban Pharmaceuticals Inc.
NDC	62175-155
Schedule	CII
Availability	—
Ingredients	methylphenidate hydrochloride[methylphenidate]

What does this imprint mean?

The imprint "UCB 583" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Methylphenidate

Uses and warnings

No boxed warning in this label, but strong warnings and contraindications are present. Contraindicated in patients with "marked anxiety, tension, and agitation" (symptoms may be aggravated), in glaucoma, in patients with motor tics or a family history of Tourette's syndrome, and with current or recent (within 14 days) MAOI use. Major warnings include sudden death and serious cardiovascular adverse events in patients with structural cardiac abnormalities or other serious heart problems; "stroke, and myocardial infarction have been reported in adults"; new or worsened psychiatric symptoms including psychosis and mania; and "temporary slowing in growth rate" in children with long-term use. It is a Schedule II controlled substance with high abuse and dependence potential.

Methylphenidate hydrochloride tablets are indicated for treatment of Attention-Deficit Hyperactivity Disorder, used as part of a comprehensive treatment program for children exhibiting "moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity," and for treatment of "narcolepsy" in adults.

Read the full drug profile →